RADIOPHARM THERANOSTICS LTD RADX
SPONSORED ADS · ADR · CUSIP 75041J101
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.45.
Biggest buyers
| SILVERARC CAPITAL MANAGEMENT, LLC | New | +187.4k |
| Affinity Asset Advisors, LLC | New | +156.2k |
| Regal Partners Ltd | New | +90.9k |
| UBS Group AG | New | +1.3k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | 0 |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Lantheus Holdings, Inc. 13G · passive investor -3.6 pts · filed 2026-09-04 | 17.3% |
| REGAL PARTNERS HOLDINGS PTY LTD 13G · institution +1.8 pts · filed 2026-01-08 | 9.1% |
Fell to 5% or below in the last year: Regal Partners Funds Management Pty Ltd (3.3%, 2026-10-14; now reported by REGAL PARTNERS HOLDINGS PTY LTD), JPMORGAN CHASE & CO (4.0%, 2026-01-16)
Insider purchases and sales in Q4 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2024.
Holders, Q4 2024
| Manager | Shares | Change |
|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC 0.19% of their portfolio | 187.4k $841.5k | New |
| Affinity Asset Advisors, LLC 0.11% of their portfolio | 156.2k $684.0k | New |
| Regal Partners Ltd 0.04% of their portfolio | 90.9k $408.2k | New |
| UBS Group AG 0.00% of their portfolio | 1.3k $5.9k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |